Skip to main content
Clinical Trials/ISRCTN16596456
ISRCTN16596456Completed未知

Real-world evidence study of primary care referrals to NHS memory clinics and the clinical and economic case for the adoption of the Integrated Cognitive Assessment to improve the dementia diagnosis pathway

Cognetivity Ltd.0 sites99 target enrollmentStarted: March 9, 2020Last updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
99

Study Overview

Brief Summary

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34932495/ (added 22/12/2021) 2023 Other publications in https://doi.org/10.3389/fpubh.2023.1240901 Health economic analysis (added 02/10/2023) 2023 Results article in https://doi.org/10.3389/fnagi.2023.1243316 (added 02/10/2023)

Study Design

Study Type
Observational

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Patients aged between 55-90 years old at the time of AV1 who are referred to the memory clinic who have the capacity to consent

Exclusion Criteria

  • 1. Upper limb arthropathy or motor dysfunction that limits the use of a tablet computer
  • 2. Visual impairment severe enough to limit the use of a tablet computer. As guidance participants who cannot read the small print in a newspaper (even with corrected vision) should be excluded
  • 3. Patients with a known diagnosis of Dementia
  • 4. Patients already receiving Cholinesterase Inhibitors and/or Memantine

Investigators

Sponsor
Cognetivity Ltd.

Similar Trials